Table 1.
Best overall response by blinded independent central review
| All patients N = 210 | ||||
|---|---|---|---|---|
| Patients with primary refractory cHL n = 71 | Remaining patients n = 139 | |||
| n | % (95% CIa) | n | % (95% CIa) | |
| ORR | 58 | 81.7 (70.7-89.9) | 93 | 66.9 (58.4-74.6) |
| CR | 25 | 35.2 (24.2-47.5) | 33 | 23.7 (16.9-31.7) |
| PR | 33 | 46.5 (34.5-58.7) | 60 | 43.2 (34.8-51.8) |
| SD | 2 | 2.8 (0.3-9.8) | 21 | 15.1 (9.6-22.2) |
| PD | 8 | 11.3 (5.0-21.0) | 24 | 17.3 (11.4-24.6) |
| NA | 3 | 4.2 (0.9-11.9) | 1 | 0.7 (0.0-3.9) |
cHL, classic Hodgkin lymphoma; CR, complete response; NA, no assessment; ORR, overall response rate; PD, progressive disease; PR, partial response; SD, stable disease.
a
Based on binomial exact CI.